Table 1 Patients admitted to the acute palliative care unit at the Cancer Clinic, St. Olavs hospital, Trondheim University Hospital during Jan 15th, 2019, and Jan 15th, 2020, according to self-reported anxiety at admission
From: Emergency palliative cancer care: anxiety and midazolam
No anxiety | Mild anxiety | Moderate and severe anxiety | Total | |
|---|---|---|---|---|
N (%) | 45 (27.4) | 57 (34.8) | 62 (37.8) | 164 (100.0) |
Age, median [IQR] | 71.0 [66.0–80.0] | 71.0 [62.0–78.0] | 72.0 [62.0–79.0] | 72.0 [62.5–79.0] |
Gender, n (%) | ||||
Male | 32 (71.1) | 32 (56.1) | 44 (71.0) | 108 (65.9) |
Female | 13 (28.9) | 25 (43.9) | 18 (29.0) | 56 (34.1) |
Social status, n (%) | ||||
Living alone | 15 (33.3) | 23 (40.4) | 20 (32.3) | 58 (35.4) |
Married/cohabitant | 30 (66.7) | 34 (59.6) | 42 (67.7) | 106 (64.6) |
Eastern Cooperative Oncology Group Performance status (ECOG PS*), n (%) | ||||
Score 1 | 4 (8.9) | 7 (12.3) | 6 (9.7) | 17 (10.4) |
Score 2 | 16 (35.6) | 25 (43.9) | 21 (33.9) | 62 (37.8) |
Score 3 | 21 (46.7) | 24 (42.1) | 31 (50.0) | 76 (46.3) |
Score 4 | 4 (8.9) | 1 (1.8) | 4 (6.5) | 9 (5.5) |
Cancer type, n (%) | ||||
GI | 21 (46.7) | 25 (43.9) | 27 (44.3) | 73 (44.8) |
Urologic | 7 (15.6) | 16 (28.1) | 16 (26.2) | 39 (23.9) |
Breast | 3 (6.7) | 7 (12.3) | 1 (1.6) | 11 (6.7) |
Lung | 0 (0.0) | 0 (0.0) | 3 (4.9) | 3 (1.8) |
Head/neck | 6 (13.3) | 3 (5.3) | 2 (3.3) | 11 (6.7) |
Other | 8 (17.8) | 6 (10.5) | 12 (19.7) | 26 (16.0) |
Metastases, n (%) | ||||
No | 6 (13.3) | 7 (12.3) | 6 (9.7) | 19 (11.6) |
Yes | 39 (86.7) | 50 (87.7) | 56 (90.3) | 145 (88.4) |
Trajectory, n (%) | ||||
Palliative cancer care | 29 (64.4) | 31 (54.4) | 28 (45.2) | 88 (53.7) |
Integrated cancer care | 15 (33.3) | 26 (45.6) | 34 (54.8) | 75 (45.7) |
Missing | 1 (2.2) | 0 (0.0) | 0 (0.0) | 1 (0.6) |
Anxiety treatment at admission, n (%) | ||||
No treatment | 34 (75.6) | 37 (64.9) | 35 (56.5) | 106 (64.6) |
Oral benzodiazepine | 9 (20.0) | 16 (28.1) | 22 (35.5) | 47 (28.7) |
Subcutaneous midazolam | 2 (4.4) | 4 (7.0) | 5 (8.1) | 11 (6.7) |
Pain at admission, n (%) | ||||
No pain | 11 (24.4) | 5 (8.8) | 9 (14.5) | 25 (15.2) |
Mild pain | 12 (26.7) | 15 (26.3) | 21 (33.9) | 48 (29.3) |
Moderate pain | 15 (33.3) | 27 (47.4) | 19 (30.6) | 61 (37.2) |
Severe pain | 7 (15.6) | 10 (17.5) | 13 (21.0) | 30 (18.3) |
Dyspnoea at admission, n (%) | ||||
No dyspnoea | 20 (44.4) | 7 (12.3) | 13 (21.0) | 40 (24.4) |
Mild dyspnoea | 13 (28.9) | 26 (45.6) | 12 (19.4) | 51 (31.1) |
Moderate dyspnoea | 7 (15.6) | 16 (28.1) | 27 (43.5) | 50 (30.5) |
Severe dyspnoea | 5 (11.1) | 8 (14.0) | 10 (16.1) | 23 (14.0) |